Literature DB >> 26576097

Acute-on-chronic liver failure: Pathogenesis, prognostic factors and management.

Sara Blasco-Algora1, José Masegosa-Ataz1, María Luisa Gutiérrez-García1, Sonia Alonso-López1, Conrado M Fernández-Rodríguez1.   

Abstract

Acute-on-chronic liver failure (ACLF) is increasingly recognized as a complex syndrome that is reversible in many cases. It is characterized by an acute deterioration of liver function in the background of a pre-existing chronic liver disease often associated with a high short-term mortality rate. Organ failure (OF) is always associated, and plays a key role in determining the course, and the outcome of the disease. The definition of ACLF remains controversial due to its overall ambiguity, with several disparate criteria among various associations dedicated to the study of liver diseases. Although the precise pathogenesis needs to be clarified, it appears that an altered host response to injury might be a contributing factor caused by immune dysfunction, ultimately leading to a pro-inflammatory status, and eventually to OF. The PIRO concept (Predisposition, Insult, Response and Organ Failure) has been proposed to better approach the underlying mechanisms. It is accepted that ACLF is a different and specific form of liver failure, where a precipitating event is always involved, even though it cannot always be ascertained. According to several studies, infections and active alcoholism often trigger ACLF. Viral hepatitis, gastrointestinal haemorrhage, or drug induced liver injury, which can also provoke the syndrome. This review mainly focuses on the physiopathology and prognostic aspects. We believe these features are essential to further understanding and providing the rationale for improveddisease management strategies.

Entities:  

Keywords:  Acute decompensation of cirrhosis; Acute on-chronic liver failure; Chronic liver failure-sequential organ failure assessment; Hepatic encephalopathy; Hepatorenal syndrome; Immune dysfunction; Liver failure; Organ failure; Severity score; Systemic inflammatory response

Mesh:

Year:  2015        PMID: 26576097      PMCID: PMC4641130          DOI: 10.3748/wjg.v21.i42.12125

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  211 in total

1.  Clinical Course of acute-on-chronic liver failure syndrome and effects on prognosis.

Authors:  Thierry Gustot; Javier Fernandez; Elisabet Garcia; Filippo Morando; Paolo Caraceni; Carlo Alessandria; Wim Laleman; Jonel Trebicka; Laure Elkrief; Corinna Hopf; Pablo Solís-Munoz; Faouzi Saliba; Stefan Zeuzem; Augustin Albillos; Daniel Benten; José Luis Montero-Alvarez; Maria Teresa Chivas; Mar Concepción; Juan Córdoba; Aiden McCormick; Rudolf Stauber; Wolfgang Vogel; Andrea de Gottardi; Tania M Welzel; Marco Domenicali; Alessandro Risso; Julia Wendon; Carme Deulofeu; Paolo Angeli; François Durand; Marco Pavesi; Alexander Gerbes; Rajiv Jalan; Richard Moreau; Pere Ginés; Mauro Bernardi; Vicente Arroyo
Journal:  Hepatology       Date:  2015-05-29       Impact factor: 17.425

2.  [Hepatic encephalopathy].

Authors:  După Andreas Blei; Juan Cordoba
Journal:  Rom J Gastroenterol       Date:  2002-06

3.  Characteristics, risk factors, and mortality of cirrhotic patients hospitalized for hepatic encephalopathy with and without acute-on-chronic liver failure (ACLF).

Authors:  Juan Cordoba; Meritxell Ventura-Cots; Macarena Simón-Talero; Àlex Amorós; Marco Pavesi; Hendrik Vilstrup; Paolo Angeli; Marco Domenicali; Pere Ginés; Mauro Bernardi; Vicente Arroyo
Journal:  J Hepatol       Date:  2013-10-12       Impact factor: 25.083

Review 4.  Hemostasis, coagulation abnormalities, and liver disease.

Authors:  Carole L Mackavey; Robert Hanks
Journal:  Crit Care Nurs Clin North Am       Date:  2013-10-20       Impact factor: 1.326

Review 5.  Infectious complications of acute and chronic liver disease.

Authors:  Bettina Leber; Walter Spindelboeck; Vanessa Stadlbauer
Journal:  Semin Respir Crit Care Med       Date:  2012-03-23       Impact factor: 3.119

6.  Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: the RELIEF trial.

Authors:  Rafael Bañares; Frederik Nevens; Fin Stolze Larsen; Rajiv Jalan; Agustín Albillos; Matthias Dollinger; Faouzi Saliba; Tilman Sauerbruch; Sebastian Klammt; Johann Ockenga; Albert Pares; Julia Wendon; Tanja Brünnler; Ludwig Kramer; Philippe Mathurin; Manuel de la Mata; Antonio Gasbarrini; Beat Müllhaupt; Alexander Wilmer; Wim Laleman; Martin Eefsen; Sambit Sen; Alexander Zipprich; Teresa Tenorio; Marco Pavesi; Hartmut H-J Schmidt; Steffen Mitzner; Roger Williams; Vicente Arroyo
Journal:  Hepatology       Date:  2013-02-15       Impact factor: 17.425

7.  Acute-on-chronic liver failure - its definition remains unclear.

Authors:  Kama Wlodzimirow; Ameen Abu-Hanna; Robert A F M Chamuleau
Journal:  J Hepatol       Date:  2013-02-24       Impact factor: 25.083

8.  Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial.

Authors:  E Akriviadis; R Botla; W Briggs; S Han; T Reynolds; O Shakil
Journal:  Gastroenterology       Date:  2000-12       Impact factor: 22.682

9.  A novel prognostic score for acute-on-chronic hepatitis B liver failure.

Authors:  Zhao-Quan Yi; Meng-Hou Lu; Xu-Wen Xu; Xiao-Yu Fu; De-Ming Tan
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2015-02-12

10.  Initial combination anti-viral therapy with lamivudine and adefovir dipivoxil decreases short-term fatality rate of hepatitis-B-virus-related acute-on-chronic liver failure.

Authors:  Jiahong Yang; Gao Chen; Xuebing Chen; Hao Zhang; Di Jiang; Guang Yang
Journal:  Virol J       Date:  2015-06-24       Impact factor: 4.099

View more
  17 in total

1.  Prognostic value of plasma level of superoxide dismutase in HBV-related acute-on-chronic liver failure.

Authors:  Naijuan Yao; Yajuan He; Yuchao Wu; Fei Wang; Zhen Tian
Journal:  BMC Gastroenterol       Date:  2022-06-25       Impact factor: 2.847

2.  Prevalence and risk factors of acute-on-chronic liver failure in a single center from Argentina.

Authors:  Cristian Dominguez; Eugenia Romero; Jorgelina Graciano; Jose Luis Fernandez; Luis Viola
Journal:  World J Hepatol       Date:  2016-12-08

3.  Molecular Adsorbent Recirculating System Can Reduce Short-Term Mortality Among Patients With Acute-on-Chronic Liver Failure-A Retrospective Analysis.

Authors:  Hans U Gerth; Michele Pohlen; Gerold Thölking; Hermann Pavenstädt; Marcus Brand; Anna Hüsing-Kabar; Christian Wilms; Miriam Maschmeier; Iyad Kabar; Josep Torner; Marco Pavesi; Vicente Arroyo; Rafael Banares; Hartmut H J Schmidt
Journal:  Crit Care Med       Date:  2017-10       Impact factor: 7.598

4.  Discovery of a Potential Plasma Protein Biomarker Panel for Acute-on-Chronic Liver Failure Induced by Hepatitis B Virus.

Authors:  Ni Zhou; Kuifeng Wang; Shanhua Fang; Xiaoyu Zhao; Tingting Huang; Huazhong Chen; Fei Yan; Yongzhi Tang; Hu Zhou; Jiansheng Zhu
Journal:  Front Physiol       Date:  2017-12-06       Impact factor: 4.566

5.  Plasma Apolipoprotein A-V Predicts Long-term Survival in Chronic Hepatitis B Patients with Acute-on-Chronic Liver Failure.

Authors:  En-Qiang Chen; Meng-Lan Wang; Dong-Mei Zhang; Ying Shi; Do-Bo Wu; Li-Bo Yan; Ling-Yao Du; Ling-Yun Zhou; Hong Tang
Journal:  Sci Rep       Date:  2017-03-30       Impact factor: 4.379

6.  Application of the Molecular Adsorbent Recirculating System in Type 1 Hepatorenal Syndrome in the Course of Alcohol-Related Acute on Chronic Liver Failure.

Authors:  Grzegorz Kade; Arkadiusz Lubas; Sebastian Spaleniak; Anna Wojtecka; Ksymena Leśniak; Sławomir Literacki; Stanisław Niemczyk; Przemysław Dyrla
Journal:  Med Sci Monit       Date:  2020-06-30

Review 7.  The Management of Glucocorticoid Therapy in Liver Failure.

Authors:  Ran Xue; Qinghua Meng
Journal:  Front Immunol       Date:  2019-10-23       Impact factor: 7.561

8.  HLA and proteasome expression body map.

Authors:  Sebastian Boegel; Martin Löwer; Thomas Bukur; Patrick Sorn; John C Castle; Ugur Sahin
Journal:  BMC Med Genomics       Date:  2018-03-27       Impact factor: 3.063

9.  A prediction model for outcome in patients with HBV-ACLF based on predisposition, injury, response and organ failure.

Authors:  Fangfang Liu; Zhengsheng Zou; Lijun Shen; Weiwei Wu; Jiajun Luo; Seth Lankford; Yongli Yang; Huang Huang; Shaoli You; Bing Zhu; Jin Li; Jinsong Mu; Yawei Zhang; Shaojie Xin
Journal:  Sci Rep       Date:  2020-11-19       Impact factor: 4.379

10.  Acute-on-chronic liver failure as a major predictive factor for mortality in patients with variceal bleeding.

Authors:  Jongbeom Shin; Jung Hwan Yu; Young-Joo Jin; Hyung Joon Yim; Young Kul Jung; Jin Mo Yang; Do Seon Song; Young Seok Kim; Sang Gyune Kim; Dong Joon Kim; Ki Tae Suk; Eileen L Yoon; Sang Soo Lee; Chang Wook Kim; Hee Yeon Kim; Jae Young Jang; Soung Won Jeong
Journal:  Clin Mol Hepatol       Date:  2020-09-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.